| E1976 |
BAY-593
|
BAY-593 is an in vivo probe and small molecule inhibitor of geranylgeranyltransferase-I (GGTase-I), blocking oncogenic YAP1/TAZ. It exhibits potent anti-tumor activity and inhibits cancer cell proliferation in vitro.
|
|
|
| S8164 |
YAP-TEAD Inhibitor 1 (Peptide 17)
|
YAP-TEAD Inhibitor 1 (Peptide 17) is a YAP-TEAD protein-protein interaction inhibitor which has potential usage in treatment of YAP-involved cancers with IC50 of 25 nM.
|
-
Adv Sci (Weinh), 2025, 12(36):e09361
-
EMBO Mol Med, 2025, 10.1038/s44321-025-00278-4
-
Stem Cell Res Ther, 2025, 16(1):489
|
|
| S0881 |
Mitochonic acid 5 (MA-5)
|
Mitochonic acid 5 (MA-5) reduces mitochondrial apoptosis via upregulation of mitophagy, regulates mitophagy via Bnip3 through the MAPK-ERK-Yap signaling pathway, and modulates mitochondrial ATP synthesis.
|
-
Front Cell Dev Biol, 2025, 13:1583951
-
Animals (Basel), 2024, 14(3):368.
-
Animals (Basel), 2024, 14(3)368
|
|
| E1598 |
VT103
|
VT103 is an orally active and selective inhibitor of TEAD1 protein palmitoylation with anti-proliferative and anti-tumor activity. It also inhibits YAP/TAZ-TEAD promoted gene transcription, blocks TEAD auto-palmitoylation and disrupts interaction between YAP/TAZ and TEAD.
|
|
|